Information Provided By:
Fly News Breaks for July 29, 2015
NUVA
Jul 29, 2015 | 09:20 EDT
As previously reported, Northland upgraded NuVasive to Outperform from Market Perform and raised its price target to $68 from $48. The firm expects 2H results to beat expectations and is a buyer ahead of Q3 results given strength in the U.S. spine market, operating performance, and leverage. Northland views the iGA platform as a "game changer" and checks show NuVasive continues to take market share.
News For NUVA From the Last 2 Days
There are no results for your query NUVA